Product NDC: | 0009-7667 |
Proprietary Name: | Cleocin |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 100 mg/1 & nbsp; clindamycin phosphate |
Administration Route(s): | VAGINAL |
Dosage Form(s): | SUPPOSITORY |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-7667 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050767 |
Marketing Category: | NDA |
Start Marketing Date: | 19990813 |
Package NDC: | 0009-7667-01 |
Package Description: | 3 SUPPOSITORY in 1 CARTON (0009-7667-01) |
NDC Code | 0009-7667-01 |
Proprietary Name | Cleocin |
Package Description | 3 SUPPOSITORY in 1 CARTON (0009-7667-01) |
Product NDC | 0009-7667 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | SUPPOSITORY |
Route Name | VAGINAL |
Start Marketing Date | 19990813 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |